Weimar W - Search Results

1

Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin.

Metselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Weimar W. Metselaar HJ, et al. Among authors: weimar w. Chest. 1990 Feb;97(2):396-9. doi: 10.1378/chest.97.2.396. Chest. 1990. PMID: 2153508

2

Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantation.

Weimar W, Metselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Jeekel J. Weimar W, et al. Transplant Proc. 1990 Feb;22(1):229-32. Transplant Proc. 1990. PMID: 2155488 No abstract available.

3

Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.

Metselaar HJ, Velzing J, Rothbarth PH, Balk AH, Mochtar B, Weimar W. Metselaar HJ, et al. Among authors: weimar w. Transplant Proc. 1989 Feb;21(1 Pt 3):2504-5. Transplant Proc. 1989. PMID: 2539677 No abstract available.

4

Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection.

Metselaar HJ, Rothbarth PH, Brouwer RM, Wenting GJ, Jeekel J, Weimar W. Metselaar HJ, et al. Among authors: weimar w. Transplantation. 1989 Aug;48(2):264-6. doi: 10.1097/00007890-198908000-00016. Transplantation. 1989. PMID: 2547256 Clinical Trial.

5

Cytomegalovirus infection and renal transplantation.

Metselaar HJ, Weimar W. Metselaar HJ, et al. Among authors: weimar w. J Antimicrob Chemother. 1989 Jun;23 Suppl E:37-47. doi: 10.1093/jac/23.suppl_e.37. J Antimicrob Chemother. 1989. PMID: 2550411 Review.

6

Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients.

Sluiters JF, Balk AH, Essed CE, Mochtar B, Weimar W, Simoons ML, Ijzerman EP. Sluiters JF, et al. Among authors: weimar w. J Clin Microbiol. 1989 Mar;27(3):529-35. doi: 10.1128/jcm.27.3.529-535.1989. J Clin Microbiol. 1989. PMID: 2654182 Free PMC article.

7

A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients.

Metselaar HJ, Velzing J, Rothbarth PH, Simoons ML, Bos E, Weimar W. Metselaar HJ, et al. Among authors: weimar w. Transplant Proc. 1987 Oct;19(5):4063-5. Transplant Proc. 1987. PMID: 2823431 No abstract available.

8

Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.

van Gelder T, Mulder AH, Balk AH, Mochtar B, Hesse CJ, Baan CC, Vaessen LM, Weimar W. van Gelder T, et al. Among authors: weimar w. J Heart Lung Transplant. 1995 Mar-Apr;14(2):346-50. J Heart Lung Transplant. 1995. PMID: 7779855 Clinical Trial.

9

Prophylactic therapy with OKT3 does not affect donor specific reactivity of peripheral blood lymphocytes from heart transplant recipients.

Jutte NH, Heyse P, Daane CR, Vaessen LM, Claas FH, Balk AH, Mochtar B, Weimar W. Jutte NH, et al. Among authors: weimar w. Transpl Immunol. 1994;2(1):22-6. doi: 10.1016/0966-3274(94)90073-6. Transpl Immunol. 1994. PMID: 8081786 Clinical Trial.

10

Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.

Balk AH, Weimar W, Rothbarth PH, Meeter K, Metselaar HJ, Mochtar B, Simoons ML. Balk AH, et al. Among authors: weimar w. Infection. 1993 Jul-Aug;21(4):195-200. doi: 10.1007/BF01728886. Infection. 1993. PMID: 8225620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters